The present disclosure pertains generally to a system for producing a suspension comprising metal ions as well as methods of using the system to produce a suspension comprising metal ions. The present disclosure pertains to the system and the methods of using the system where the suspension comprises copper ions.
Suspensions comprising metal ions are known to be useful in the making of pharmaceutical treatments for various conditions. For example, suspensions comprising copper ions are known to be treatments for conditions including but not limited to vaginitis, bacterial vaginosis, hemorrhoids, vaginal dryness, imbalances in vaginal pH, bacterial infections caused by gonorrhea, chlamydia, streptococcus, staphylococcus, enterobacter, E. coli and pseudomonas, protozoan infections caused by trichomonas, pelvic inflammatory disease, viral infections caused by shingles and the associated postherpetic neuralgia (PHN) (a chronic, painful condition that can follow shingles), herpes (I and II), HPV and HIV, fungal infections caused by yeast candida, thrush and other fungi, and causing conditions such as athlete's foot, ringworm and toenail fungus, impetigo, rosacea, psoriasis, eczema, warts, sun/wind damage, dry skin, age spots, pigmentation, scarring, blisters, boils, cysts, pimples, cuts, scratches, burns, abrasions, splinters, insect bites and stings, animal bites and scratches, ulcers, loss of elasticity or collagen, wrinkles, sagging skin, acne, measles, chicken pox, exposure to sexually transmitted diseases, the risk of undesired pregnancy (contraception), canker sores, mouth sores, mouth ulcers, colds, sinusitis, rhinosinusitis, sore throat, nasal discharge, congestion, runny nose, bronchitis, allergies, asthma, tonsillitis, wheezing, sneezing, ear infections, earache, pressure in the ears, cough, hoarseness, laryngitis, sore gums, periodontal disease, bad breath, tooth decay, plaque, biofilm, and the presence of pathogens and microbes on the skin that is an inevitable consequence of daily life. Thus, it is desirable for a safe and efficient method to provide suspensions comprising metal ions.
Existing methods of producing metal ion suspensions include dissolving metal salts such as copper sulfate into a solvent. However, metal salts may be made using harsh chemicals. For example, copper sulfate may be produced by treating copper metal with hot concentrated sulfuric acid or, alternatively, by treating copper oxides with dilute sulfuric acid. The use of such methods may introduce residual reactants, such as sulfuric acid, which may be an irritant or even potentially dangerous to a person. Additionally, solvents into which metal salts, such as copper sulfate, are dissolved will necessarily comprise the anionic molecule or molecules of the salt, for example sulfate in the case of copper sulfate. It is possible that the anionic molecules of a metal salt are themselves an irritant or reactive. Thus, it is desirable to control the composition of the final suspension comprising metal ions to a degree unavailable through the dissolving of metal salts into a solution.
Existing methods of ionizing a large mass of metal involve contacting a large mass of metal with a solvent to leach metal ions into the solution. However, many conventional methods are slowed by insufficient surface area contact between the metal and the solution. Thus, it is difficult for these methods to obtain sufficient ionization to be practical in producing large volumes of suspension comprising sufficiently high concentrations of metal ions.
Disclosed herein are systems and methods for producing a suspension comprising metal ions.
Accordingly, in one aspect described herein, the system comprises a basket, a vessel, and a solution, wherein the solution is placed in the vessel, and the basket is loaded with solid metal. The basket may then be inserted into the vessel such that the metal load contained in the basket is fully or partially submerged in the solution, thereby allowing for metal ions to be leached out of the solid metal load and into the solution.
In some embodiments, the basket of the system comprises a permeable floor so as to allow a solution to come into contact with the metal load. In some embodiments, the basket and its metal load are fully submerged in the solution. In some embodiments, the basket and its metal load are only partially submerged in the solution.
In some embodiments of the system, the basket and the vessel are cylindrical. In some embodiments, the basket and the vessel are composed of plastic, glass, cloth, inert metals, or stainless steel that do not substantially react with the solution placed in the vessel. In some embodiments, the basket or the vessel is composed of medical grade stainless steel, such as 316 stainless steel.
In some embodiments, the basket of the system comprises one or more spacers to separate individual pieces of the metal load to increase the metal-surface-to-solution contact. In certain embodiments the more than one spacers run from end-to-end of the basket and do not intersect.
In some embodiments, the vessel may have a flat bottom. In some embodiments, the vessel may have a rounded bottom. In some embodiments, the vessel may have an open top. In some embodiments, the vessel may have a lid, or the top may be otherwise sealable.
In some embodiments, the solution is buffered. In some embodiments, the buffer comprises at least one of acetate, acetic acid, phosphate, a phosphoric acid, or at least one salt of acetate, acetic acid, phosphate, or phosphoric acid. In some embodiments, the solution is a saline solution.
In some embodiments, the system further comprises a temperature control element to heat, cool, or maintain steady the temperature of the system. In some embodiments, the system further comprises an agitation element to agitate at least one of the basket, the vessel, and the solution.
In another aspect described herein, the method comprises loading the basket with a metal load, filling the vessel with an appropriate amount of solution, immersing the metal load in the solution placed in the vessel, and allowing metal ions to be leached from the metal into the solution.
In some embodiments, one metal or one type of substantially pure metal load may be loaded into the basket. In some embodiments, the one metal or one type of substantially pure metal is copper. In some embodiments, more than one metal or more than one type of substantially pure metal load may be loaded into the basket.
In some embodiments, the metal loaded into the basket has dimensions to increase solution-to-metal-surface-are contact. In some embodiments, the metal loaded into the basket is metal strips. In some embodiments, the metal is loaded into the basket between pairs of spacers so that one or zero pieces of metal are loaded between each pair of spacers in the basket.
In embodiments, an appropriate amount of metal is loaded into the basket to produce a suspension with a predetermined metal ion concentration. In some embodiments, additional metal is loaded into the basket to increase the amount of metal ions leached in the solution. In some embodiments, less metal is loaded into the basket to decrease the amount of metal ions leached into the solution.
In embodiments, an appropriate amount of solution is placed in the vessel to produce a suspension with a predetermined metal ion concentration. In embodiments, the amount of solution placed in the vessel will define a solution depth below which the basket and its metal load is submerged in the solution. In some embodiments, the volume of solution placed in the vessel may be substantially equal to the volume of the vessel. In some embodiments, the volume of solution placed in the vessel will be substantially less than the volume of the vessel. In some embodiments, additional solution is placed in the vessel to decrease the concentration of the metal ions leached into the solution. In some embodiments, less solution is placed in the vessel to increase the concentration of the metal ions leached into the solution.
In some embodiments, the solution is buffered. In some embodiments, the buffer comprises at least one of acetate, acetic acid, phosphate, a phosphoric acid, or at least one salt of acetate, acetic acid, phosphate, or phosphoric acid. In some embodiments, the solution requires no buffer, or the solution is substantially free of buffers or buffering agents. In some embodiments, the solution is a saline solution.
In embodiments, the basket containing its metal load is disposed in the vessel into which the solution is placed. In some embodiments, the basket and its metal load are fully submerged in the solution placed in the vessel. In some embodiments, the basket and its metal load are partially submerged in the solution placed in the vessel.
In some embodiments, the basket and its metal load are disposed in the vessel for a predetermined time between about 0.5 hours and several days (e.g., 1, 2, 3, 4, 5, 6, 7, or 10 days), several weeks (e.g., 1, 2, 3, 4, 5, or 6 weeks), or several months (e.g., 1, 2, 3, 4, 5, 6, or 12 months). In some embodiments the predetermined time is between about 0.5 hours and about 72 hours. In some embodiments, the time is about 0.5, about 1, about 1.5, about 2, about 2.5, about 3, about 4, about 5, about 6, about 12, about 18, about 24, about 36, about 48, about 60, or about 72 hours.
In some embodiments, the method further comprises heating or cooling the solution to a predetermined temperature while the basket and its metal load is disposed in the vessel. In some embodiments, the solution is heated to a temperature of about 37° C. and held at about 37° C. for a predetermined period of time. In some embodiments, the solution is heated to a temperature of about 50° C. and held at about 50° C. for a predetermined period of time. In some embodiments, the solution is held at room temperature for a predetermined period of time.
In some embodiments, the method further comprises agitating at least one of the basket, the vessel, and the solution while the basket and its metal load are disposed in the vessel. In some embodiments, the solution is circulated in the vessel independently of agitating the vessel or basket. In some embodiments, at least one of the vessel and the basket are shaken or rocked. In some embodiments, the basket is lifted and lowered into the vessel.
In some embodiments, the basket and the remaining metal load is removed from the vessel after a predetermined time. In some embodiments, the remaining metal removed from the vessel is measured. In some embodiments, the amount of metal ion leached into the solution is measured.
In some embodiments, the basket and the remaining metal load may be re-immersed in the vessel and solution after it is removed. In some embodiments, the basket and the remaining metal load is immersed in the same or another vessel into which another solution has been placed.
In some embodiments, precipitate is removed from the suspension comprising metal ions. In some embodiments, the suspension comprising metal ions is filtered.
In some embodiments, the concentration of the metal ions in the suspension comprising metal ions are increased. In some embodiments, the concentration of metal ions in the suspension comprising metal ions are increased by repeating the method with at least one new or additional metal load. In some embodiments, the ion concentration is increased by adding additional metal to the metal load. Any appropriate amount of additional metal may be added to the metal load. For instance, an additional load of metal substantially equal to the initial load of metal may be added to double the metal load, or an additional load of metal substantially equal to half the initial load of metal may be added to increase the metal load by 50%. In some embodiments, metal is added by adding additional sheets of metal, each sheet being substantially equal to the other sheets. For example, an initial metal load of 47 substantially equal metal sheets, such as copper, may be increased about 62% by adding 29 additional metal sheets.
In some embodiments, the concentration of metal ions in the suspension comprising metal ions are increased by evaporating liquid away from the suspension comprising metal ions. In some embodiments, liquid in the suspension comprising metal ions is evaporated away to an extent that the remaining product is a powder. Such powders may be dry or may be substantially free of liquid. In some embodiments where a powder is produced, the powder may have the same mass or substantially the same mass as the mass of the initial metal load. In some embodiments where a powder is produced, the powder may have more mass than the initial metal load. In some embodiments where a powder is produced, the powder will have less mass than the initial metal load. In some embodiments, a second solution or suspension may be added to the powder, and the powder may be resuspended in the second solution or suspension to produce a further suspension comprising metal ions. In some embodiments, the second solution or suspension and the powder is agitated or shaken in order to resuspend the powder.
In some embodiments, the concentration of the metal ions in the suspension comprising metal ions is decreased. In some embodiments, the concentration of metal ions in the suspension comprising metal ions are decreased by adding at least one liquid to the suspension comprising metal ions. In some embodiments, the at least one liquid added to the suspension comprising metal ions may be substantially identical to the solution placed into the vessel before the metal ions were leached into the solution.
In some embodiments, the concentration of the metal ions in the suspension comprising metal ions is adjusted by adding another suspension comprising metal ions with a different concentration.
In some embodiments, the method may further comprise the step of combining a suspension comprising metal ions may with various carriers. In some embodiments, the carrier may be creams, lotions, gels, foams, pastes, other solutions, tampons, suppositories, body wipes, wound dressings, skin patches or suture material to obtain other forms of metal ion treatments.
Some embodiments of the present disclosure pertain to a system used to produce a suspension comprising copper ions. Some embodiments of the present disclosure pertain to a method to produce a suspension comprising copper ions.
In certain embodiments, the suspension comprising metal ions may be further modified to supply a pharmaceutically acceptable treatment.
System
The technology includes a system comprising a basket and a vessel to provide a metal-ion composition.
Basket and Metal Load
The basket of the system comprises a base. The base comprises a floor and at least one wall defining the perimeter of the basket (
The basket may be composed of any appropriate material. Appropriate materials may include plastics, glasses, cloths, or inert metals. Inert metals refer to any metal or metal composite which is substantially not reactive with a solution placed in the vessel of the system. In one embodiment, the inert metal is stainless steel. In one embodiment, the inert metal is a medical grade stainless steel, such as 316 stainless steel.
The floor is not impermeable to liquids including a solution within the vessel of the system or metal ions leached from the metal load of the basket and disposed in the solution within the vessel. The floor may be made of interwoven or welded wires (
The at least one wall defines the perimeter of the base. It may run along the outer edge of the floor. It may run from the floor to the height of the basket. Alternatively, it may be positioned above the floor of the basket. Alternatively, it may be positioned below the height of the basket. Alternatively, it may be placed above the floor of the basket and below the height of the basket. In one embodiment, the at least one wall may comprise more than one piece of material. The more than one piece of material comprising the at least one wall may be flush against one another. Alternatively, the more than one piece of material comprising the at least one wall may be spaced apart from one another, thereby defining a gap, a space, a slit, or an aperture through which a liquid may flow.
The basket of the system may comprise a handle attached to its base. The handle may be welded into the inside wall of the basket system's base. The handle will be positioned in such a manner as to not interfere with the metal load in the basket.
The basket of the system may comprise a frame. The frame may comprise one or more separators which the metal load may rest upon or may otherwise be used to separate various components from the metal load from other components of the metal load. The frame may be placed roughly two-thirds up the height of the basket base. For example, a basket base with a height of about 15 cm may include a frame placed at about 12 cm above the bottom of the basket base.
The basket of the system may comprise one or more spacer. The one or more spacers allow the metal load of the basket to be placed into the basket with reduced contact between individual pieces of the metal load and/or the materials of the basket. In some embodiments, the one or more spacer may run from one side of the basket's perimeter to another side of the basket's perimeter. In some embodiments, the spacers may be attached to the basket's at least one wall at one or both ends. In some embodiments, a series of spacers running from one side of the basket's perimeter to another side of the basket's perimeter and attached to the basket's at least one wall at one or both ends define a series of slits, spaces, or gaps (
In an embodiment comprising a plurality of spacers, at least one spacer may run parallel to at least one other spacer. In an embodiment comprising a plurality of spacers, at least one spacer may not run parallel to at least one other spacer, and the at least one spacer will not make contact with the at least one other spacer. For example, at least one spacer may run from one end of the basket's perimeter to another end of the basket's perimeter making a v-wave, and at least one other spacer may also run from one end of the basket's perimeter to another end of the basket's perimeter also making a v-wave, but the at least one spacer and the at least one other spacer do not come into contact (
Vessel
The vessel of the system comprises a bottom and at least one wall defining the perimeter of the vessel. The vessel may have any dimensions such that the basket of the system may be partially or fully disposed and removed from the vessel. The vessel may be cylindrical, rectangular, cubic, triangular, octagonal, tetrahedral, conic, pyramidic, near-spherical, or an irregular shape.
The bottom and at least one wall of vessel are solid, and the vessel is capable of holding a solution. The vessel may be composed of any appropriate material. Appropriate materials may include plastics, glasses, or inert metals. Inert metals refer to any metal or metal composite which is substantially not reactive with a solution placed in the vessel of the system. In one embodiment, the inert metal is stainless steel. In one embodiment, the inert metal is a medical grade stainless steel, such as 316 stainless steel.
The top of the vessel may be open. Alternatively, the top of the vessel may be a lid which is capable of being opened or closed.
Flat-Bottom Vessels
The vessel of the system may have a flat bottom (
These vessels may be of any shape with a flat bottom including rectangular, cubic, triangular, octagonal, tetrahedral, cylindrical, conic, pyramidic, near-spherical, or an irregular shape with a flat bottom. Preferred embodiments of the vessel are cylindrical (
The inner-diameter (d) of the vessel may be any inner-diameter such that the basket of the system and its metal load can be disposed and removed from the vessel. The height (h) of the vessel may be any height such that the basket of the system and its metal load is fully or partially submerged in a solution contained in the vessel.
The vessel volume (V) of the vessel is the volume of the vessel's cavity defined by the walls and bottom of the vessel. This volume may be approximated by well-known mathematical equations. The vessel volume of the vessel may be any vessel volume such that a solution contained in the vessel may fully or partially submerge the basket of the system and its metal load disposed in the vessel.
The amount of solution contained in the vessel will define a solution depth. The solution depth is the height within the vessel below which the contents of the vessel are fully submerged. The solution depth of a vessel may be any solution depth greater than about zero and less than or equal to about the height of the vessel. In some embodiments the solution depth is about half the height of the vessel. The solution depth may be defined as the height within the vessel below which the contents of the vessel are fully submerged while the vessel contains only the solution and is otherwise empty. Alternatively, the solution depth may be defined as the height within the vessel below which the contents of the vessel are fully submerged while the vessel contains the solution and the basket of the system. Alternatively, the solution depth may be defined as the height within the vessel below which the contents of the vessel are fully submerged while the vessel contains the solution, the basket of the system, and the basket's metal load. Generally, the solution depth in a vessel may be approximated by well-known mathematical calculations.
Round-Bottom Vessels
The vessel of the system may have a curved bottom (
These vessels may be of any shape with a curved bottom including rectangular, cubic, triangular, octagonal, tetrahedral, cylindrical, conic, pyramidic, near-spherical, spherical, or an irregular shape with a curved bottom. Preferred embodiments of the vessel are cylindrical with a curved bottom (
A curved-bottom vessel has an inner-diameter (d) and a height (h). The inner-diameter may be any inner-diameter such that the basket of the system and its metal load can be disposed and removed from the vessel. The height may be any height such that the basket of the system and its metal load is fully or partially submerged in a solution contained in the vessel
The vessel volume (V) of the vessel is the volume of the vessel's cavity defined by the walls and bottom of the vessel. The volume may be approximated by well-known mathematical equations. This approximation of the vessel volume may include the base volume defined by the curved bottom. The approximation of the vessel volume may not include the base volume defined by the curved bottom. The vessel volume of the vessel may be any vessel volume such that a solution contained in the vessel may fully or partially submerge the basket of the system and its metal load disposed in the vessel.
The amount of solution contained in the vessel will define a solution depth. The solution depth is the height within the vessel below which the contents of the vessel are fully submerged. The solution depth in a curved-bottom vessel may be measured from the bottom of the non-curved-base portion of the vessel, above the curved base. Alternatively, the solution depth may be measured from the bottom of the curved base. The solution depth of a vessel may be any solution depth greater than about zero and less than or equal to about the height of the vessel. In some embodiments the solution depth is about half the height of the vessel. The solution depth may be defined as the height within the vessel below which the contents of the vessel are fully submerged while the vessel contains only the solution and is otherwise empty. Alternatively, the solution depth may be defined as the height within the vessel below which the contents of the vessel are fully submerged while the vessel contains the solution and the basket of the system. Alternatively, the solution depth may be defined as the height within the vessel below which the contents of the vessel are fully submerged while the vessel contains the solution, the basket of the system, and the basket's metal load. Generally, the solution depth in a vessel may be approximated by well-known mathematical calculations.
Solution
The solution may be any solution capable of leaching metal ions from a solid piece of metal disposed in the solution over time. The solution may be buffered by any buffer known in the art. For example, the solution may be buffered with acetate, acetic acid, phosphate, a phosphoric acid, any salts of the buffers, or any combination of the buffers. In some embodiments, the solution requires no buffer, or the solution is substantially free of buffers or buffering agents. The solution may further comprise a dissolved salt. For example, the solution may comprise sodium chloride and thereby be a saline solution. In some embodiments, the solution is a saline solution. In some embodiments, the saline solution uses any appropriate saline dissolved in the solution. The solution may be of any appropriate pH, such as a pH of about 5.0. In some embodiments, the solution has a pH between about 4.7 and about 7.
The solution is not required to fill the otherwise empty vessel. Nor is the solution required to fill the vessel when the basket of the system is in the vessel. Nor is the solution required to fill the vessel when the basket of the system and its metal load are in the vessel.
Additional Components
It is envisioned that the system may benefit from the addition of further components.
In preferred embodiments, the system comprises a temperature control element configured to heat, cool, or maintain the temperature of the solution placed in the vessel. The temperature control element may be configured to heat the solution to a temperature between about 35° C. to about 100° C. Preferably, the temperature control element may be configured to heat the solution to a temperature between about 35° C. and 70° C. In one embodiment, the temperature control element is configured to heat the solution to a temperature of about 37° C. and maintain the temperature of the solution at about 37° C. for a predetermined period of time. In another embodiment, the temperature control element is configured to heat the solution to a temperature of about 50° C. and maintain the temperature of the solution at about 50° C. for a predetermined period of time. In another embodiment, the solution is held at room temperature for a predetermined period of time.
The system may comprise an agitation element configured to agitate at least one of the basket, the vessel, and the solution. In one embodiment, the agitation element is configured to circulate the solution in the vessel independently of agitating the vessel or basket. In one embodiment, the agitation element is configured to shake or rock at least one of the vessel and the basket. In one embodiment, the agitation element is configured to lift and lower the basket in the vessel.
Process
The technology includes a process of using a basket, a vessel, a solution, and a metal load to produce a metal-ion composition.
Loading the Basket
At least one appropriate metal is loaded into the basket of the system. Appropriate metals are any metals which it is desirable to leach metal ions from. For example, copper may be an appropriate metal when the solution to be produced is to comprise copper ions. The at least one appropriate metal may comprise metals of different type (e.g. a copper metal and a silver metal). The at least one appropriate metal may comprise metals of different purity (e.g. a pure copper metal and a metal which is 90% or more copper). Appropriate metals are not inactive with respect to the solution used in the process.
The metal is preferably loaded so as to provide a substantial amount of metal surface area to be in contact with the solution when the basket is submerged into the vessel. By providing a substantial amount of metal surface area to be in contact with the solution, the rate of metal ion leaching will be increased. In some embodiments, the metal is loaded into the basket so that its longest dimension is its height. In some embodiments, the metal is loaded into the basket so that its longest dimension is its length. In some embodiments, the metal is a strip of metal.
In some embodiments where the basket comprises spacers, only one piece of metal is placed between a pair of spacers. In some embodiments, a plurality of pieces of metal are placed between a pair of spacers.
An appropriate amount of metal is placed in the basket. An appropriate amount of metal is any amount of metal which, when submerged in the solution in the vessel for an appropriate amount of time at an appropriate temperature, will produce a solution with a concentration of metal ion within a desired range.
In some embodiments, the total metal loaded into the basket may have a mass between about 100 milligrams and about 15 kilograms. For example, the total metal loaded into the basket may have a mass of about 0.1 kilograms, 0.2 kilograms, 0.4 kilograms, 0.6 kilograms, 0.8 kilograms, 1 kilogram, 1.2 kilograms, 1.4 kilograms, 1.6 kilograms, 1.8 kilograms, 1.9 kilograms, 2.1 kilograms, 2.3 kilograms, 2.5 kilograms, 2.7 kilograms, 2.9 kilograms, 3.1 kilograms, 3.3 kilograms, 3.5 kilograms, 4 kilograms, 5 kilograms, 6 kilograms, 7 kilograms, 8 kilograms, 9 kilograms, 10 kilograms, 12.25 kilograms, 14 kilograms, or 15 kilograms. In some embodiments, the total metal loaded into the basket may have a mass of more than about 15 kilograms. In some embodiments, the total metal loaded into the basket may have a mass of less than about 100 milligrams.
An aspect of the present technology is that the amount of metal loaded into the basket may be increased to increase the metal-to-solution ratio when the basket is disposed into the vessel of the system, thereby increasing the concentration of the metal ion in the suspension comprising metal ions. Another aspect of the present technology is that amount of metal loaded into the basket may be decreased to decrease the metal-to-solution ratio when the basket is disposed into the vessel of the system, thereby decreasing the concentration of the metal ion in the suspension comprising metal ions.
Filling the Vessel with Solution
An appropriate amount of solution is placed in the vessel. An appropriate amount of solution is any amount of solution which, when the basket with the metal load is disposed into the vessel is fully or partially submerged. That is, an appropriate amount of solution will define a solution depth within the vessel which is partially or fully above the basket and its metal load once the basket and its metal load is disposed into the vessel. For example,
The volume of solution placed in the vessel may be any volume greater than zero milliliters and less than or about equal to the volume of the vessel. The volume of solution placed in the vessel may be substantially equal to the volume of the vessel in the absence of the basket of the vessel and the metal load loaded into the basket. The volume of the solution placed in the vessel may be substantially equal to the volume of the vessel in the absence of the metal load less the volume excluded by the basket. The volume of the solution placed in the vessel may be substantially equal to the volume of the vessel less the volume excluded by the basket and the metal load loaded into the basket.
For example, the volume of the solution to be placed into the vessel may be between about 200 milliliters and about 65 liters. In some embodiments, the volume of the solution placed in the vessel may be about 52.6 liters. In some embodiments the volume of the solution placed in the vessel is about 62.3 liters. In some embodiments the solution volume placed in the vessel is about 25 liters.
An aspect of the present technology is that the amount of solution placed into the vessel may be increased to decrease the metal-to-solution ratio when the basket with its metal load is disposed into the vessel of the system, thereby decreasing the concentration of the metal ion in the suspension comprising metal ions. Another aspect of the present technology is that amount of solution placed into the vessel may be decreased to increase the metal-to-solution ratio when the basket with its metal load is disposed into the vessel of the system, thereby increasing the concentration of the metal ion in the suspension comprising metal ions.
The solution may be any solution capable of leaching metal ions from a solid piece of metal disposed in the solution over time. The solution may be buffered by any buffer known in the art. For example, the solution may be buffered with acetate, acetic acid, phosphate, a phosphoric acid, any salts of the buffers, or any combination of the buffers. In some embodiments, the solution requires no buffer, or the solution is substantially free of buffers or buffering agents. The solution may further comprise a dissolved salt. For example, the solution may comprise sodium chloride and thereby be a saline solution. In some embodiments, the solution is a saline solution. In some embodiments, the saline solution uses any appropriate saline dissolved in the solution. The solution may be of any appropriate pH, such as a pH of about 5.0. In some embodiments, the solution has a pH between about 4.7 and about 7.
In preferred embodiments, the temperature of the solution is controlled by any tools known in the art. The temperature of the solution may be room temperature (about 20-21° C.). Alternatively, the solution may be heated to a temperature between about 35° C. to about 100° C. In one embodiment, the solution is heated to a temperature of about 37° C. and held at about 37° C. for a predetermined period during which the basket and its metal load are partially or fully submerged in the solution. In another embodiment, the solution is heated to a temperature of about 50° C. and held at about 50° C. for a predetermined period of time during which the basket and its metal load are partially or fully submerged in the solution.
An aspect of the present technology is that the temperature of the solution may be adjusted to speed up or slow down the rate metal ions are leached into the solution while the basket and its metal load is fully or partially submerged in the solution compared with the rate metal ions are leached into the solution when the temperature of the solution is about room temperature. In preferred embodiments, the solution is heated to a temperature above that of room temperature so as to speed up the rate at which metal ions are leached into the solution. In preferred embodiments, the temperature of the solution is held at a temperature above that of room temperature for a predetermined period during which the basket and its metal load are partially or fully submerged in the solution so as to speed up the rate at which metal ions are leached into the solution.
Disposing the Basket and Metal Load in the Vessel and Submerging the Metal Load in the Solution
The basket containing its metal load is disposed into the vessel into which the solution is placed such that the solution depth is above the bottom of the basket. That is the basket is partially or fully submerged in the solution.
An aspect of the disclosed technology is that the basket containing its metal load may be disposed in the vessel and be partially or fully submerged in the solution for a predetermined period of time in order to promote the leaching of metal ions from the metal into the solution. The time during which the basket may be disposed in the vessel and be partially or fully submerged in the solution may be any appropriate time that allows for a desired amount of metal ions to be leached from the metal into the solution. In some embodiments of the technology the time is between about 0.5 hours and several days (e.g., 1, 2, 3, 4, 5, 6, 7, or 10 days), several weeks (e.g., 1, 2, 3, 4, 5, or 6 weeks), or several months (e.g., 1, 2, 3, 4, 5, 6, or 12 months). In some embodiments the predetermined time is between about 0.5 hours and about 72 hours. In some embodiments, the time is about 0.5, about 1, about 1.5, about 2, about 2.5, about 3, about 4, about 5, about 6, about 12, about 18, about 24, about 36, about 48, about 60, or about 72 hours.
In preferred embodiments, the temperature of the solution is controlled while the basket and its metal load are partially or fully submerged in the solution by any tools known in the art. In one embodiment the temperature of the solution is maintained at room temperature while the basket and its metal load are partially or fully submerged in the solution. In another embodiment, the temperature of the solution is maintained at a temperature between about 35° C. to about 70° C. while the basket and its metal load are partially or fully submerged in the solution. In another embodiment, the temperature of the solution is maintained at a temperature between about 37° C. to about 50° C. while the basket and its metal load are partially or fully submerged in the solution. The temperature of the solution may be adjusted to a temperature above that of room temperature and that temperature may be maintained while the basket and its metal load is partially or fully submerged in the solution.
During the time that the basket and its metal load is disposed in the vessel the vessel, the solution, the basket and its metal load, or a combination of any components of the system may be agitated. This agitation may be provided by any means known in the art and may include circulating the solution in the vessel independently of agitating the vessel or basket, shaking or rocking at least one of the vessel and the basket, lifting and then re-lowering the basket into the vessel. An aspect of the technology is that any appropriate amount of agitation may be provided increased metal surface-to-solution contact, and/or increase the rate of leaching metal ions from the metal, and/or increase the amount of metal ions leached from the metal into the solution, and/or decrease the period of time during which the basket and its metal load are disposed in the solution within the vessel.
After the predetermined time the basket and the remaining metal load is removed from the vessel and the solution. The amount of metal ions leached from the metal may be calculated using well-known methods. Methods to estimate the amount of metal ions leached from the metal may be calculated by comparing the mass of the metal load after removal to the mass of the metal load before it was disposed in the vessel and the solution. The amount of metal ions in the solution may be determined using, for example, mass spectrometry (e.g. inductively coupled plasma mass spectrometry, ICP-MS). The removed metal load may be re-immersed in the solution if it is desired that further metal ions be leached from the metal load. Alternatively, the metal load may be immersed in a separate solution.
After the basket and the metal load is removed, precipitate in the solution may be removed by use of a filter or any other method known in the art. Alternatively, the precipitate may be retained in the solution or resuspended by agitation or shaking. In some embodiments, the suspension comprising metal ions is agitated or shaken for about 15 seconds to suspend metal ions in the suspension comprising metal ions.
The concentration of metal ions in the suspension may be adjusted by methods known in the art. For example, additional liquids may be added to the suspension comprising leached metal ions thereby diluting the final concentration of the metal ions in the suspension. The liquid could be any liquid including water, a liquid with a composition identical to the solution before the metal ions were leached into the solution, or another suspension comprising metal ions. Alternatively, the suspension may be treated with appropriate air pressure and/or heat to evaporate liquid from the suspension thereby concentrating the final concentration of the metal ions in the suspension. In some embodiments, liquid in the suspension comprising metal ions is evaporated away to an extent that the remaining product is a powder. Such powders may be dry or may be substantially free of liquid. In some embodiments where a powder is produced, the powder may have the same mass or substantially the same mass as the mass of the initial metal load. In some embodiments where a powder is produced, the powder may have more mass than the initial metal load. In some embodiments where a powder is produced, the powder will have less mass than the initial metal load. In some embodiments, a second solution or suspension may be added to the powder, and the powder may be resuspended in the second solution or suspension to produce a further suspension comprising metal ions. In some embodiments, the second solution or suspension and the powder is agitated or shaken in order to resuspend the powder. Alternatively, another suspension comprising metal ions at a higher concentration could be added to the suspension comprising metal ions to increase the final concentration of the metal ions compared to the suspension comprising metal ions.
A suspension with a desired concentration of metal ions may be mixed with various carriers to facilitate application or delivery of the suspension comprising metal ions. Suitable carriers include creams, lotions, gels, foams, pastes, other solutions, tampons, suppositories, body wipes, wound dressings, skin patches and suture material to obtain other forms of metal ion treatments. The carriers may comprise other active components or consist only of non-active components. The resulting compounds may be used as treatments for use on anatomical tissue of the genital-rectal areas, the oral-respiratory-otic areas, and/or the dermatological areas of the body.
The following specific examples are to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever. Without further elaboration, it is believed that one skilled in the art can, based on the description herein, utilize the present disclosure to its fullest extent.
A cylindrical, flat-bottom vessel was produced (
A cylindrical, round-bottom vessel was produced (
A cylindrical basket with a wired bottom was produced (
A cylindrical, flat-bottom vessel was produced. Sufficient solution was placed into the vessel to define a volume depth of about 19.3 centimeters. A cylindrical basket with a wired bottom was produced. The basket was loaded with copper metal with heights of about 18 centimeters. The basket with the copper metal load was inserted into the vessel so that all of the copper was fully submerged in the solution (
A metal load comprising 8 copper metal strips was provided. The copper metal was fully submerged into 1 liter of leaching solution, and the copper ions in the copper metal load were leached into the solution at 37° C. After about 24 hours, the remaining solid copper was removed from the solution. The 1 liter suspension comprising copper metal ions was concentrated by evaporating away liquid from the suspension comprising copper metal ions to an extent that a powder was produced. This powder was substantially free of liquid. It was determined that its mass was 0.71 grams. 30 grams of a suspension consisting of 46 μg/mL of copper in 0.9% saline with 0.8 g/L NaPO4 (3VM1000) were added to the powder, and the powder was resuspended in the suspension by agitation. 70 grams of VersaBase® cream made by Professional Compounding Centers of America (PCCA) of Houston, Tex. was added to the suspension comprising the resuspended powder and thoroughly mixed. The resulting cream composition comprised about 590 μg of copper ions per gram of composition.
It is to be understood that the disclosed subject matter is not limited in its application to the details of construction and to the arrangements of the components set forth in the following description or illustrated in the drawings. The disclosed subject matter is capable of other embodiments and of being practiced and carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein are for the purpose of description and should not be regarded as limiting.
As such, those skilled in the art will appreciate that the conception, upon which this disclosure is based, may readily be utilized as a basis for the designing of other structures, methods, and systems for carrying out the several purposes of the disclosed subject matter. It is important, therefore, that the claims be regarded as including such equivalent constructions insofar as they do not depart from the spirit and scope of the disclosed subject matter.
Although the disclosed subject matter has been described and illustrated in the foregoing exemplary embodiments, it is understood that the present disclosure has been made only by way of example, and that numerous changes in the details of implementation of the disclosed subject matter may be made without departing from the spirit and scope of the disclosed subject matter, which is limited only by the claims which follow.
The present patent application is a divisional of U.S. patent application Ser. No. 16/283,605, filed Feb. 22, 2019, which incorporates-by-reference U.S. patent application Ser. No. 13/841,882, titled “Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Genital-Rectal Areas of the Body;” U.S. patent application Ser. No. 13/841,992, titled “Topical Copper Ion Treatments and Methods of Making Topical Copper Ion Treatments for Use in Various Anatomical Areas of the Body;” U.S. patent application Ser. No. 13/842,387, titled “Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Dermatological Areas of the Body;” U.S. patent application Ser. No. 14/168,310, titled “Therapeutic Wound Dressing with Solid Copper Material;” U.S. patent application Ser. No. 09/336,724, now U.S. Pat. No. 6,190,365, titled “Vaginal douche applicator and method of vaginal deodorization using the same;” U.S. patent application Ser. No. 10/077,256, now U.S. Pat. No. 6,589,216, titled “Vaginal douches, vaginal douche applicators and methods of vaginal douching;” U.S. patent application Ser. No. 10/371,395, now U.S. Pat. No. 7,276,056, titled “Methods of treating abnormal biological conditions by vaginal douching;” U.S. patent application Ser. No. 10/847,299, now U.S. Pat. No. 7,270,653, titled “Methods of treating abnormal biological conditions using metal oxides;” U.S. patent application Ser. No. 11/810,685, now U.S. Pat. No. 8,118,789, titled “Deodorizer devices, systems and methods for controlling perspiration-related body odor;” U.S. patent application Ser. No. 13/116,334, now U.S. Pat. No. 8,178,039, titled “Methods for controlling perspiration-related body odor;” U.S. patent application Ser. No. 13/842,310, titled “Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Oral-Respiratory-Otic Areas of the Body;” and U.S. patent application Ser. No. 15/265,570, titled “Methods of Treatment Using Topical Copper Ion Formulations;” International Patent Application Publication Nos. WO 2014/150703, titled “Topical copper ion treatments in the genital-rectal areas of the body;” WO 2014/151350, titled “Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body;” WO 2014/150719, titled “Topical copper ion treatments in the dermatological areas of the body;” WO 2015/116520, titled “Therapeutic wound dressing with solid copper material;” WO 03/070301, titled “Vaginal douches, vaginal douche applicators and methods of vaginal douching;” WO 2014/150716, titled “Topical copper ion treatments;” and WO 2018/052995, titled “Methods of treatment using topical copper ion formulations,” in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
2994642 | Bossard | Aug 1961 | A |
3393678 | Pacini | Jul 1968 | A |
3803308 | Zipper | Apr 1974 | A |
3814809 | Gordon | Jun 1974 | A |
3930834 | Schulteis et al. | Jan 1976 | A |
3934580 | Cournut | Jan 1976 | A |
4039406 | Stanley et al. | Aug 1977 | A |
4136172 | Walliczek | Jan 1979 | A |
4242192 | Dunning, Jr. | Dec 1980 | A |
4246896 | Horne, Jr. et al. | Jan 1981 | A |
4294894 | Vellucci | Oct 1981 | A |
4332791 | Raaf et al. | Jun 1982 | A |
4391270 | Uragami | Jul 1983 | A |
4407786 | Drake et al. | Oct 1983 | A |
4457909 | Tames | Jul 1984 | A |
4618489 | Pollock et al. | Oct 1986 | A |
4642230 | Whitehead et al. | Feb 1987 | A |
4661101 | Sustmann | Apr 1987 | A |
4675014 | Sustmann et al. | Jun 1987 | A |
4680309 | Maurer | Jul 1987 | A |
4795628 | Afseth | Jan 1989 | A |
4959216 | Daunter | Sep 1990 | A |
5037634 | Williams et al. | Aug 1991 | A |
5063065 | Bazterrica et al. | Nov 1991 | A |
5164367 | Pickart | Nov 1992 | A |
5211940 | Ishiguro et al. | May 1993 | A |
5389360 | Mobley et al. | Feb 1995 | A |
5415866 | Zook | May 1995 | A |
5425862 | Hartmann | Jun 1995 | A |
5456602 | Sakuma | Oct 1995 | A |
5458746 | Burgess et al. | Oct 1995 | A |
5631017 | Sharpe et al. | May 1997 | A |
5798116 | Brown | Aug 1998 | A |
5981475 | Reynolds | Nov 1999 | A |
6022545 | Schmittmann et al. | Feb 2000 | A |
6042848 | Lawyer et al. | Mar 2000 | A |
6087549 | Flick | Jul 2000 | A |
6123925 | Barry et al. | Sep 2000 | A |
6153210 | Roberts et al. | Nov 2000 | A |
6231889 | Richardson et al. | May 2001 | B1 |
6294186 | Beerse et al. | Sep 2001 | B1 |
6296881 | Hata et al. | Oct 2001 | B1 |
6319391 | Holderness et al. | Nov 2001 | B1 |
6383352 | Shyu | May 2002 | B1 |
7005556 | Becker et al. | Feb 2006 | B1 |
7087249 | Burrell et al. | Aug 2006 | B2 |
7252839 | Hallinen et al. | Aug 2007 | B2 |
7604819 | Huey et al. | Oct 2009 | B2 |
7776915 | Morariu | Aug 2010 | B2 |
7857961 | Hayashi et al. | Dec 2010 | B2 |
8118028 | Karpati | Feb 2012 | B2 |
8135466 | Fuller et al. | Mar 2012 | B2 |
8182800 | MacDonald | May 2012 | B2 |
10398733 | Abbott et al. | Sep 2019 | B2 |
11000545 | Abbott et al. | May 2021 | B2 |
11007143 | Abbott et al. | May 2021 | B2 |
11083750 | Abbott et al. | Aug 2021 | B2 |
11193184 | Abbott et al. | Dec 2021 | B2 |
11253544 | Abbott et al. | Feb 2022 | B2 |
11298316 | Abbott | Apr 2022 | B2 |
11318089 | Abbott et al. | May 2022 | B2 |
20020114767 | Rolla | Aug 2002 | A1 |
20020136758 | Jehan | Sep 2002 | A1 |
20030099718 | Burrell et al. | May 2003 | A1 |
20030163149 | Heisinger | Aug 2003 | A1 |
20030166510 | Pickart | Sep 2003 | A1 |
20040171519 | DiSpirito et al. | Sep 2004 | A1 |
20040254097 | Patt | Dec 2004 | A1 |
20050048007 | Ruggles | Mar 2005 | A1 |
20050123620 | Chiou | Jun 2005 | A1 |
20050169852 | Roberge et al. | Aug 2005 | A1 |
20050226945 | Ruwart | Oct 2005 | A1 |
20060122095 | Delvin et al. | Jun 2006 | A1 |
20060216258 | Singleton et al. | Sep 2006 | A1 |
20060222622 | Faure | Oct 2006 | A1 |
20060253078 | Wu et al. | Nov 2006 | A1 |
20070014839 | Bracht | Jan 2007 | A1 |
20070053849 | Doyle et al. | Mar 2007 | A1 |
20070167971 | Huey et al. | Jul 2007 | A1 |
20070187327 | George et al. | Aug 2007 | A1 |
20070190175 | Cummins et al. | Aug 2007 | A1 |
20070243263 | Trogolo | Oct 2007 | A1 |
20070275021 | Lee et al. | Nov 2007 | A1 |
20070275073 | Huey et al. | Nov 2007 | A1 |
20070276308 | Huey et al. | Nov 2007 | A1 |
20080029915 | Waldron | Feb 2008 | A1 |
20080032119 | Feldhahn et al. | Feb 2008 | A1 |
20080081077 | Faryniarz et al. | Apr 2008 | A1 |
20080112988 | Frank et al. | May 2008 | A1 |
20080125686 | Lo | May 2008 | A1 |
20080195033 | Eagleson et al. | Aug 2008 | A1 |
20080274065 | Robinson et al. | Nov 2008 | A1 |
20080286180 | Jones | Nov 2008 | A1 |
20080286212 | Cooley | Nov 2008 | A1 |
20080295843 | Haas | Dec 2008 | A1 |
20080299155 | McCook et al. | Dec 2008 | A1 |
20080311165 | Gabbay | Dec 2008 | A1 |
20080311218 | Oronsky et al. | Dec 2008 | A1 |
20080317836 | Dorogi et al. | Dec 2008 | A1 |
20090004294 | Margulies et al. | Jan 2009 | A1 |
20090018213 | Snyder et al. | Jan 2009 | A1 |
20090148540 | Martin et al. | Jun 2009 | A1 |
20090163551 | Earnest | Jun 2009 | A1 |
20090186071 | Huey et al. | Jul 2009 | A1 |
20090246292 | Seville et al. | Oct 2009 | A1 |
20090287131 | Neron et al. | Nov 2009 | A1 |
20090304813 | Hickok | Dec 2009 | A1 |
20090311305 | Abbott et al. | Dec 2009 | A1 |
20100003198 | Stolmeier et al. | Jan 2010 | A1 |
20100015898 | An et al. | Jan 2010 | A1 |
20100055138 | Margulies et al. | Mar 2010 | A1 |
20100068161 | Todary Michael | Mar 2010 | A1 |
20100068297 | Naughton | Mar 2010 | A1 |
20100100188 | Fuller et al. | Apr 2010 | A1 |
20100158989 | Mentkow et al. | Jun 2010 | A1 |
20100228174 | Huey et al. | Sep 2010 | A1 |
20100233248 | Huey et al. | Sep 2010 | A1 |
20100307503 | Iwamoto et al. | Dec 2010 | A1 |
20110064826 | Spurge | Mar 2011 | A1 |
20110086088 | Berry | Apr 2011 | A1 |
20110195108 | Fujimori et al. | Aug 2011 | A1 |
20120063262 | Imran | Mar 2012 | A1 |
20120071807 | McClure, Jr. | Mar 2012 | A1 |
20120071858 | Abbott et al. | Mar 2012 | A1 |
20120089068 | McClure, Jr. | Apr 2012 | A1 |
20130123716 | Abbott et al. | May 2013 | A1 |
20130226061 | Dickson | Aug 2013 | A1 |
20140005116 | Obayan et al. | Jan 2014 | A1 |
20140178313 | Okumura et al. | Jun 2014 | A1 |
20140221948 | Riesinger | Aug 2014 | A1 |
20140271495 | Abbott et al. | Sep 2014 | A1 |
20140271797 | Abbott et al. | Sep 2014 | A1 |
20140271798 | Abbott et al. | Sep 2014 | A1 |
20140271919 | Abbott et al. | Sep 2014 | A1 |
20160008272 | Abbott et al. | Jan 2016 | A1 |
20170000823 | Abbott et al. | Jan 2017 | A1 |
20170101699 | Moskovchenko et al. | Apr 2017 | A1 |
20180071206 | Abbott et al. | Mar 2018 | A1 |
20180133250 | Abbott | May 2018 | A1 |
20190343876 | Abbott et al. | Nov 2019 | A1 |
20200206264 | Abbott et al. | Jul 2020 | A1 |
20200270723 | Abbott et al. | Aug 2020 | A1 |
20200281972 | Abbott et al. | Sep 2020 | A1 |
20210220397 | Abbott et al. | Jul 2021 | A1 |
20210220398 | Abbott et al. | Jul 2021 | A1 |
20210220399 | Abbott et al. | Jul 2021 | A1 |
20210228476 | Abbott et al. | Jul 2021 | A1 |
Number | Date | Country |
---|---|---|
04029672 | Sep 1973 | AU |
2020201265 | Sep 2021 | AU |
2478137 | Feb 2006 | CA |
2912628 | Jan 2022 | CA |
101203232 | Jun 2008 | CN |
101534823 | Sep 2009 | CN |
0115130 | Jan 1987 | EP |
1236461 | Sep 2002 | EP |
2762125 | Aug 2016 | EP |
2751544 | Jan 1998 | FR |
521215 | May 1940 | GB |
1333906 | Oct 1973 | GB |
1493750 | Nov 1977 | GB |
2449893 | Dec 2008 | GB |
2003212765 | Jul 2003 | JP |
2051154 | Dec 1995 | RU |
2155047 | Aug 2000 | RU |
1538101 | Jan 1990 | SU |
WO-9215329 | Sep 1992 | WO |
WO-9958095 | Nov 1999 | WO |
WO-2001026665 | Apr 2001 | WO |
WO-0239963 | May 2002 | WO |
WO-0241862 | May 2002 | WO |
WO-02096202 | Dec 2002 | WO |
WO-2004073758 | Sep 2004 | WO |
WO-2005072691 | Aug 2005 | WO |
WO-2006096937 | Sep 2006 | WO |
WO-2008037262 | Apr 2008 | WO |
WO-2009088270 | Jul 2009 | WO |
WO-2011069184 | Jun 2011 | WO |
WO-201 2063262 | May 2012 | WO |
WO-2014151350 | Sep 2014 | WO |
WO-2018052995 | Mar 2018 | WO |
WO-2020171994 | Aug 2020 | WO |
WO-2021236231 | Nov 2021 | WO |
Entry |
---|
US 11,052,109 B2, 07/2021, Abbott et al. (withdrawn) |
US 11,229,598 B2, 01/2022, Abbott et al. (withdrawn) |
US 11,266,597 B1, 03/2022, Abbott et al. (withdrawn) |
“10 Homemade Gargles That Heal”, Reader's Digest of Canada, www.readersdigest.ca/health/conditions/gaggle-gargles/, Jan. 4, 2008 (3 pages). |
“About the Study: ELVIS COVID-19 Study Full Information”, The University of Edinburgh, URL <https://www.ed.ac.uk/usher/elvis-covid-19/about-the-study>, published Jun. 24, 2020 (4 pages). |
“Antimicrobial Copper FAQs”, CDA Publication 201, Copper Development Association, Hemel Hempstead, United Kingdom, 2010 (8 pages). |
“Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis”, ClinicalTrials.gov, https://clinicaltrials.gov/ct2/history/NCT02332148?V_3, dated Aug. 19, 2015 (6 pages). |
“Buffer Reference Center”, https://www.sigmaaldrich.com/life-science/core-bioreagents/biological-buffers/learning-center/buffer-reference-center.html, Oct. 26, 2008 (6 pages). |
“Copper Sulfate”, extract from Extoxnet: Extension Toxicology Network, <http://pmep.cce.cornell.edu/profiles/extoxnet/carbaryl-dicrotophos/copper-sulfate-ext.html>, May 1994 (2 pages). |
“Copper Sulphate's Role in Agriculture”, Excerpt from PAN Pesticides Database—Chemicals (1 page). |
“Dangers of Copper Compounds (Sulfate, etc.)”, Pubchem.ncbi.nlm.nih.gov/compound/Copper_sulfate#section=Top, 2007 (17 pages). |
“Difference Between 304 vs 316 Stainless Steel”, Eagle Stainless Tube & Fabrication, Inc., https://eagletube.com/about-us/news/304-vs-316-stainless-steel, Jun. 21, 2018 (2 pages). |
“Lowering Infection Rates in Hospitals and Healthcare Facilities—The Role of Copper Alloys in Battling Infectious Organisms”, Copper, BioHealth Partnership Publication, Edition 1, Mar. 2007, 26 pages. |
“New Molecular Test Available to Diagnose Trichomonas Vaginalis in Asymptomatic and Symptomatic Females”, PR Newswire, Oct. 18, 2012, 3 pages. |
“Pelvic Inflammatory Disease (PID)”, CDC Fact Sheet, Centers for Disease Control, Dec. 12, 2012, 6 pages. |
“Visual Analogue Scale”, https://web.archive.org/web/20150804080655/https://www.physio-pedia.com/Visual_ Analogue_Scale, Aug. 4, 2015, accessed Dec. 13, 2017 (6 pages). |
“WOMAC Osteoarthritis Index,” https://web.archive.org/web/20150907191904/https://www.physio-pedia.com/WOMAC_Osteoarthritis_Index, Sep. 7, 2015, accessed Dec. 13, 2017 (4 pages). |
Al-Kharafi, et al., “Selective dissolution of brass in salt water”, Journal of Applied Electrochemistry, 34:47-53, 2004 (7 pages). |
Amazon.com search for “Mouthwash”, https://www.amazon.com/s/ref=sr_nr_n_0?fst=p90x%3A1%2Cas%3Aoff&rh=n%3A3760911%2Cn%3A10079992011%2Cn%3A3778161%2Ck%3Amouthwash&keywords=mouthwash&ie=UTF8&qid=1502940655&rnid=11055981, dated Aug. 16, 2017 (11 pages). |
Anthoni, F. “The Chemical Composition of Seawater”, http://www.seafriends.org.nz/oceano/seawater.htm, downloaded Jul. 28, 2016 (10 pages). |
ASTM International, Designation: D1688-12, “Standard Test Methods for Copper in Water”, dated 2012, accessed Oct. 24, 2018 (10 pages). |
AZO Materials, “Medical Applications of Stainless Steel 304 (UNS S30400)”, azom.com/Articles.aspx?=6641, Aug. 30, 2012 (3 pages). |
Bauer, “Understanding radiation dermatitis”, American Nurse Today, 11(1):13-15, Jan. 2016 (3 pages). |
Bauer, “Understanding radiation dermatitis”, URL<http://old.woundcareadvisor.com/understanding-radiation-dermatitis/>, Wound Care Advisor, vol. 5, No. 3, May/Jun. 2016 (6 pages). |
Beigel, J.H. et al., “Remdesivir for the Treatment of Covid-19—Final Report”, The New England Journal of Medicine, 383(19):1813-1826, published online Oct. 9, 2020 (14 pages). |
Ben-Hur, et al., “Phosphorus Burns: The Antidote: A New Approach”, British Journal of Plastic Surgery, 25:245-249, 1972 (5 pages). |
Bianchetti, M. G., et al., “Body fluids and salt metabolism—Part I”, Italian Journal of Pediatrics, 35:36, Nov. 19, 2009 (6 pages). |
Biocompatible, definition from Cambridge Dictionary, URL <https://dictionary.cambridge.org/us/dictionary/english/biocompatible>, accessed Oct. 26, 2020 (6 pages). |
Blakley, B.R. “Overview of Copper Poisoning”, Merck Manual: Veterinary Manual, https://www.merckvetmanual.com/toxicology/copper-poisoning/overview-of-copper-poisoning, 2018 (3 pages). |
Blanc, C. et al., “Galvanic coupling between copper and aluminium in a thin-layer cell”, Corrosion Science, 52(3):991-995, 2010 (6 Pages). |
Borkow, G. et al., “Copper as a Biocidal Tool”, Current Medicinal Chemistry, 12:2163-2175 (2005) (13 pages). |
Cancer Facts & Figures 2016, American Cancer Society, URL <https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2016.html>, 2016 (72 pages). |
Cao, “Man Sperm Self Report”, Harbin Publishing House, p. 27, Mar. 2012 (2 pages)—with English Translation. |
CDA Research Group, Inc., “A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Tolerability of 3VM1001 Cream for the Treatment of Pain Associated With Post-Herpetic Neuralgia: A Proof of Concept Study”, Identifier NCT03421613, published on clinicaltrials.gov <URL: https://www.clinicaltrials.gov/ct2/show/NCT03421613>, published Jul. 10, 2018 (8 pages). |
CDA Research Group, Inc., “A Double-blind, Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Proof of Concept Study”, Identifier: NCT02332148, Published on ClinicalTrials.Gov, <URL: https://clinicaltrials.gov/ct2/show/NCT02332148>, Published Aug. 21, 2015 according to ClinicalTrials.Gov (6 pages). |
CDA Research Group, Inc., “A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Dose Ranging Study”, Identifier: NCT03142178 published on clinicaltrials.gov <URL: https://www.clinicaltrials.gov/ct2/show/ NCT03142178 >, published Jul. 6, 2018 according to ClinicalTrials.Gov (9 pages). |
CDA Research Group, Inc., “Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis”, U.S. National Library of Medicine, Clinical Trial NCT02332148, https://clinicaltrials.gov/ct2/show/NCT02332148, Aug. 21, 2015, accessed Dec. 12, 2017 (5 pages). |
Centers for Disease Control, “CDC No Longer Recommends Oral Drug for Gonorrhea Treatment”, Press Release, Aug. 9, 2012, 1 page. |
Centers for Disease Control. “Pelvic Inflammatory Disease (PID)”, CDC Fact Sheet, Dec. 12, 2012, 6 pages. |
Collins, Reflections of Dentifrice Ingredients, Benefits and Recommendations: A Peer-Reviewed Publication, www.ineedce.com, accessed https://www.dentalacademyofce.com/courses/2086/pdf/1103cei_dentifrices_web.pdf, Oct. 2009 (11 pages). |
Copper Gluconate, except from Wikipedia, https://en.wikipedia.org/wiki/Copper_gluconate, Mar. 29, 2017 (1 page). |
Copper Glycinate Product Data Sheet, https://www.lookchem.com/Copper-glycinate/, dated 2008, accessed Aug. 30, 2018 (2 pages). |
Cortes, et al., “The use of copper to help prevent transmission of SARS-coronavirus and influenza viruses. A general review”, Diagnostic Microbiology and Infectious Disease, 98:115176, available online Aug. 15, 2020 (5 pages). |
Database WPI, Week 199640, Thompson Scientific, London GB, AN 1996-400647, XP002765918, 1996 (2 pages). |
Database WPI, Week 200375, Thompson Scientific, AN 2003-793474, XP002767346, 2003 (2 pages). |
De Rauglaudre, G. et al., “Tolerance of the association sucralfate / Cu—Zn salts in radiation dermatitis”, Annales de dermatologie, 1:11-15 (2008)—English Abstract (5 pages). |
Dispose—definition, https://www.merriam-webster.com/dictionary/dispose, downloaded Jun. 24, 2018 (1 page). |
Dragani, R. “Does Salt Change the pH of Water?”, https://sciencing.com/does-salt-change-ph-water-4577912.html., downloaded Dec. 31, 2019, Apr. 19, 2018 (3 pages). |
Duguid, R., “Copper-inhibition of the growth of oral streptococci and actinomyces”, Biomaterials, 4:225-227, Jul. 1983 (3 pages). |
Edematous—Definition from The Medical Dictionary of the Free Dictionary Online, https://medical-dictionary.thefreedictionary.com/edematous, accessed Mar. 7, 2018 (7 pages). |
European Extended Search Report issued in EP14767396.6, dated Feb. 9, 2017 (10 pages). |
European Extended Search Report issued in EP14768757.8, dated Dec. 6, 2016 (9 pages). |
European Extended Search Report issued in EP14768896.4, dated Feb. 27, 2017 (8 pages). |
European Extended Search Report issued in EP20185469.2, dated Oct. 9, 2020 (10 pages). |
European Extended Search Report issued in European Patent Application No. EP20161252.0, dated Jun. 17, 2020 (9 pages). |
European Extended Search Report, issued in European Patent Application No. 17851454.3, dated Jul. 10, 2020 (14 pages). |
European Partial Supplementary Search Report issued in EP17851454.3, dated Apr. 6, 2020 (14 pages). |
Extended European Search Report issued in EP14767738.9, dated Jan. 2, 2017 (8 pages). |
Faltermeier, R. B., “The Evaluation of Corrosion Inhibitors for Application to Copper and Copper Alloy Archaeological Artefacts”, Thesis Submitted for the Degree of Doctor of Philosophy in the Faculty of Science of the University of London, Department of Conservation and Museum Studies, Institute of Archaeology, University College London, University of London, Jul. 1995 (332 pages). |
Fenelon, A.M. et al., “The electrochemical synthesis of polypyrrole at a copper electrode: corrosion protection properties”, Electrochimica Acta, 47:4467-4476, 2002 (10 pages). |
Gerasimov, V. V. et al., “Effect of Temperature on the Rate of Corrosion of Metals”, Russian Chemical Bulleting, pp. 1192-1197, Oct. 6, 1957 (6 pages). |
Google Search “Copper Salt for Sore Throat ‘Coronavirus’”, URL https://www.google.com/search?source=hp&ei=YhxEX5fdBvOuytMPmca9cAo&q=coppe . . . >,, dated Aug. 24, 2020 (2 pages). |
Google Search, “copper in sea salt”, URL <https://www.google.com/search?q=copper+in+sea+salt&ei=TRrWYJyaCemr5NoPvImPiA . . . >, accessed Jun. 25, 2021 (2 pages). |
Google Search, “Copper phosphate buffered saline”, URL: <https://scholar.google.com/scholar?hl=en&as_sdt=0%2C47&q=copper+phosphate+buffered . . . >, accessed Aug. 5, 2021 (2 pages). |
Google Search, “dead sea salt and acetate buffer mouthwash”, URL <https://www.google.com/search?q=dead+sea+salt+and+acetate+buffer+mouthwash&ei=d . . . >, accessed Jun. 25, 2021 (2 pages). |
Google Search, “mouthwash dead sea salt and acetate buffer”, URL <https://google.com/search?q=mouthwash+dead+sea+salt+and+acetate+buffer&tbm= . . . >, accessed Jun. 25, 2021 (2 pages). |
Gray, L.W. et al., “Urinary Copper Elevation in a Mouse Model of Wilson's Disease Is a Regulated Process to Specifically Decrease the Hepatic Copper Load”, PLoS One, 7(6):e38327, Jun. 22, 2012 (11 pages). |
Higdon, J. et al., “Copper”, Linus Pauling Institute, Oregon State University, Apr. 2003, 8 pages. |
International Search Report and Written Opinion issued by the U.S. Patent and Trademark Office as International Searching Authority, in International Application No. PCT/US21/24555, dated Jul. 8, 2021 (9 pages). |
International Search Report and Written Opinion issued by the U.S. Patent and Trademark Office as International Searching Authority, issued in International Application No. PCT/US2020/17454, dated Jun. 23, 2020 (12 pages). |
International Search Report and Written Opinion issued by U.S. Patent and Trademark Office as International Searching Authority, in International Application No. PCT/US17/51356, dated Jan. 18, 2018 (11 pages). |
Ion, Wikipedia, https://en.wikipedia.org/wiki/Ion, accessed Aug. 30, 2018 (11 pages). |
Iqbal, K. et al., “Role of Different Ingredients of Tooth Pastes and Mouthwashes in Oral Health”, Journal of the Pakistan Dental Association, 20(03):163-170, Jul.-Sep. 2011 (8 pages). |
Khaled, K.F., “Studies of the corrosion inhibition of copper in sodium chloride solutions using chemical and electrochemical measurements”, Materials Chemistry and Physics, 125:427-433, 2011 (7 pages). |
Kirkpatrick, K., “Does saltwater work as mouthwash?”, http://health.howstuffworks.com/wellness/oral-care/products/saltwater-as-mouthwash.htm, available online Sep. 18, 2011, accessed Mar. 4, 2019 (6 pages). |
Lindeburg, M.R., Chemical Engineering Reference Manual for the PE Exam, 7th Edition, Professional Publications, Inc., Belmont, CA, 2013, p. 20-10 (3 pages). |
Malik, R. “Warm Saline Rinses”, http://www.nature.com/articles/sj.bdj.2009.1093.pdf, accessed Dec. 31, 2019, Br. Dental J., 207(11):520, 2009 (2 page). |
Maltz, M. et al., “Effect of copper fluoride and copper sulfate on dental plaque, Streptococcus mutans and caries in hamsters”, Scand. J. Dent. Res., 96:390-392, Oct. 1, 1988 (3 pages). |
Marques, M.R.C. et al., “Simulated Biological Fluids with Possible Application in Dissolution Testing”, Dissolution Technologies, 18(3):15-28, Aug. 2011 (14 pages). |
Metiko{hacek over (s)}-Hukovic, M. et al., “Copper Corrosion at Various pH Values with and without the Inhibitor”, Journal of Applied Electrochemistry, 30:617-624, 2000 (8 pages). |
Michels, H.T. et al., “Copper Alloys for Human Infectious Disease Control”, presented at Materials Science and Technology Conference, Pittsburgh, PA, Copper for the 21st Century Symposium, Sep. 25-28, 2005, 11 pages. |
Moore, R.L. et al., “Evaluating the Anti-Plaque Capabilities of a Copper-Containing Prophylaxis Paste”, J. Periodontal., 60(2):78-80, Feb. 1989 (3 pages). |
Mulligan, A.M. et al., “The effect of increasing copper content in phosphate-based glasses on biofilms of Streptococcus sanguis”, Biomaterials, 24:1797-1807, 2003 (11 pages). |
Nkonzo, N., “Antimicrobial Copper”, International Copper Association, Copper Development Association, May 5, 2010, 6 pages. |
Owen, D.H. et al., “A Vaginal Fluid Simulant”, Contraception, 59(2):91-95, Feb. 1999 (5 pages). |
Perrie, Y. et al., “Chapter 1: Controlling Drug Delivery”, FASTtrack: Pharmaceutics—Drug Delivery and Targeting, Second Edition, Sample Chapter, 14, Jun. 2012 (26 pages). |
Pramanik, et al., “A novel study of antibacterial activity of copper iodide nanoparticle mediated by DNA and membrane damage”, Colloids and Surfaces B: Biointerfaces, 96:50-55, published online Apr. 5, 2012 (6 pages). |
Ramachandran, S. et al., “Gluconic Acid: Properties, Applications and Microbial Production”, Food Technol. Biotechnol., 44(2):185-195, 2006 (11 pages). |
Read, A.J., “Dissolution of Copper in Weakly Acidic Solutions”, The Journal of Physical Chemistry, 76(24):3656-3663, 1972 (8 pages). |
Robinson, J., “No improvement in mortality rates for COVID-19 patients treated with remdesivir”, the Pharmaceutical Journal, DOI:10.1211/PJ.2020.20208045, published online Jun. 8, 2020 (3 pages). |
Roldan, S, et al., “Biofilms and the tongue: therapeutical approaches for the control of halitosis”, Clin. Oral Invest., 7:189-197, 2003 (9 pages). |
Rosenhein, L.D., “The Household Chemistry of Cleaning Pennies”, Applications and Analogies, Journal of Chemical Education, 78(4):513-515, Apr. 2001 (3 pages). |
Sawyer, D.T., “Metal-Gluconate Complexes”, Chem. Rev., 64(6):633-643, 1964 (11 pages). |
Saxer, U P et al., “New Studies on Estmated and Actual Toothbrushing Times and Dentifrice Use”, J. Clin. Dent., 9(2):49-51, 1998 (1 page)—Abstract Only. |
Shackel, N.A. et al., “Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial”, MJA, 167:134-136, Aug. 4, 1997 (3 pages). |
Solioz, “Dry Copper Kills Bacteria on Contact”, Science Daily, Feb. 22, 2011, 4 pages. |
Stein, R., “Gonorrhea Evades Antibiotics, Leaving Only One Drug to Treat Disease”, www.npr.org/blogs/health, Aug. 10, 2012, 5 pages. |
Tamba, B.I. et al., “Common Trace Elements Alleviate Pain in an Experimental Mouse Model”, Journal of Neuroscience Research, 91:554-561, 2013 (8 pages). |
VersaBase Cream, Product Information Document, from PCCA, https://pccarx.com/Products/ProductCatalog?pid=30-3641, accessed Dec. 31, 2019 (4 pages). |
Wang, et al., “Family Planning Technology”, Shanghai Science and Technology Press, p. 334, Dec. 31, 1997 (2 pages)—English Excerpt. |
Wikipedia, “Acetic acid”, https://en.wikipedia.org/wiki/Acetic_acid, accessed Oct. 14, 2019 (19 pages). |
Wikipedia, “Buffer Solution”, Wikipedia, the Free Encyclopedia, https://en.wikipedia.org/wiki/Buffer_Solution, accessed Apr. 7, 2017 (8 pages). |
Wikipedia, “Copper(I) chloride”, https://en.wikipedia.org/wiki/Copper(I)_chloride, accessed Oct. 13, 2019 (8 pages). |
Wikipedia, “Saline (Medicine)”, URL <https://en.wikipedia.org/wiki/Saline_(medicine)>, accessed Jul. 21, 2021 (9 pages). |
Wikipedia, “Salt (chemistry)”, https://en.wikipedia.org/wiki/Salt_(chemistry), accessed Oct. 14, 2019 (6 pages). |
Wikipedia, “Suspension (chemistry)”, https://en.wikipedia.org/wiki/Suspension_(chemistry), accessed Oct. 13, 2019 (3 pages). |
Wong, R. K. S. et al., “Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group”, Support Care Cancer, DOI 10.1007/s00520-013-1896-2, published online Aug. 14, 2013 (16 pages). |
Yassin, N. et al., “Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis”, Drug Design, Development and Therapy, 9:1491-1498, 2015 (8 pages). |
Zatcoff, R.C. et al., “Treatment of tinea pedis with socks containing copper-oxide impregnated fibers”, The Foot, 18:136-141 (2008) (6 pages). |
Zwirner, E., “5 Advantages of Vertical Storage Tanks”, https://www.zwirnerequipment.com/blog/5-advantages-vertical-storage-tanks/, Oct. 20, 2014 (2 pages). |
Physiological Saline, definition from APA Dictionary of Psychology,, <URL: https://dictionary.apa.org/physiological-saline[Oct. 5, 2021 11:47:23 AM], 1 page. |
Kole, A., et al., “Acute radiation dermatitis in breast cancer patients: challenges and solutions”, Breast Cancer—Targets and Therapy, 9:313-323, 2017 (11 pages). |
Ryan, J., et al., “Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients”, Author Manuscript published in final edited form as Radiat Res., 180(1):34-43, Jul. 2013 (20 pages). |
Ryan, J., “Ionizing Radiation: The Good, the Bad, and the Ugly”, Author Manuscript published in final edited form as J. Invest Dermatol, 132(3 0 2):985-993, Mar. 2012 (16 pages). |
Sims, A., “‘Breast Cancer Isn't Sexy’: Woman Shares Post-Radiation Images to Show Reality of Disease”, The Independent, <URL: https://www.independent.co.uk/life-style/health-and-families/health-news/breast-cancer-isn-t-sexy-woman-shares-postradiation-images-to-show-reality-of-disease-a6709516.html>, Oct. 26, 2015 (4 pages). |
Williams, M., et al., “Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity”, Int. J. Radiat. Oncol. Biol. Phys, 36(2):345-349, 1996 (5 pages). |
Leventhal, J., et al., “Radiation Dermatitis: Recognition, Prevention, and Management”, Oncology (Williston Park), 31(12):885-887, 894-899, Dec. 15, 2017 (10 pages). |
Tuck, et al., “3.07: Corrosion of Copper and its Alloys”, Shreir's Corrosion, vol. 3, pp. 1937-1973, 2010 (38 pages). |
Number | Date | Country | |
---|---|---|---|
20210363607 A1 | Nov 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16283605 | Feb 2019 | US |
Child | 17392735 | US |